The enzyme cofactor biotin (vitamin H or B7) is an energetically expensive molecule whose de novo biosynthesis requires 20 ATP equivalents. It seems quite likely that diverse mechanisms have evolved to tightly regulate its biosynthesis. Unlike the model regulator BirA, a bifunctional biotin protein ligase with the capability of repressing the biotin biosynthetic pathway, BioR has been recently reported by us as an alternative machinery and a new type of GntR family transcriptional factor that can repress the expression of the bioBFDAZ operon in the plant pathogen Agrobacterium tumefaciens. However, quite unusually, a closely related human pathogen, Brucella melitensis, has four putative BioR-binding sites (both bioR and bioY possess one site in the promoter region, whereas the bioBFDAZ [bio] operon contains two tandem BioR boxes). This raised the question of whether BioR mediates the complex regulatory network of biotin metabolism. Here, we report that this is the case. The B. melitensis BioR ortholog was overexpressed and purified to homogeneity, and its solution structure was found to be dimeric. Functional complementation in a bioR isogenic mutant of A. tumefaciens elucidated that Brucella BioR is a functional repressor. Electrophoretic mobility shift assays demonstrated that the four predicted BioR sites of Brucella plus the BioR site of A. tumefaciens can all interact with the Brucella BioR protein. In a reporter strain that we developed on the basis of a double mutant of A. tumefaciens (the ⌬bioR ⌬bioBFDA mutant), the ␤-galactosidase (␤-Gal) activity of three plasmid-borne transcriptional fusions (bioBbme-lacZ, bioYbme-lacZ, and bioRbme-lacZ) was dramatically decreased upon overexpression of Brucella bioR. Real-time quantitative PCR analyses showed that the expression of bioBFDA and bioY is significantly elevated upon removal of bioR from B. melitensis. Together, we conclude that Brucella BioR is not only a negative autoregulator but also a repressor of expression of bioY and bio operons that separately function in biotin transport and the biosynthesis pathway.
B
iotin (vitamin H or B7) is a covalently bound enzyme cofactor required by three domains of life (1) . This requirement of biotin has long been recognized in a class of important biotin-dependent enzymes involved in central metabolism, such as carboxylases and decarboxylases (2) . Generally, bacterial biotin metabolism encompasses the following three processes: transport/uptake, de novo synthesis, and utilization (1, 3, 4) . In microorganisms with a full capability of synthesizing biotin, four universal genes (bioF, bioA, bioD, and bioB) appear to constitute the majority of the biotin biosynthetic pathway (1, 5) . In Escherichia coli, which defines the paradigm, biotin synthesis proceeds via a four-step path with pimeloyl-acyl carrier protein (ACP) as the precursor (6) . Recently, we found that the generation of pimeloyl moiety in earlier steps of biotin synthesis is involved in a modified type II fatty acid biosynthetic pathway in E. coli (6) (7) (8) . In the BioC-BioH pathway of pimelate synthesis, BioC methylates malonyl coenzyme A (malonyl-CoA; or ACP) and gives a methyl malonyl-thioester destined to fatty acid biosynthesis to act as a primer (6, 7, 9) , whereas the bioH gene product demethylates the pimeloyl-ACP methyl ester to form pimeloyl-ACP after two rounds of the fatty acid elongation cycle (6, 7, 10) . The subsequent four-step pathway functions in assembling the double rings of the biotin molecule (6-8) (Fig. 1A) . First, BioF (7-keto-8-aminopelargonic acid synthase) condenses the activated form of pimelic acid (pimeloyl-ACP) with L-alanine. Second, BioA (7, 8 -diaminopelargonic acid synthase) catalyzes the generation of 7,8-diaminopelargonic acid that is followed by the BioD (dethiobiotin [DTB] synthase)-mediated formation of the ureido ring in this molecule. Finally, BioB (biotin synthase) converts dethiobiotin into biotin. In contrast, the microorganisms that possess only an incomplete biotin synthesis pathway (e.g., Lactococcus probiotic bacteria and human pathogen Streptococcus species) seem likely to have evolved an alternative mechanism of biotin scavenging to fulfill their metabolic requirements (2, 3, 11) (Fig. 1A) . Energy-coupling factor (ECF)-type transporters have been identified for vitamin uptake in prokaryotes (12) (13) (14) . This tripartite ECF-type transporter contains three elements: S component (a membrane-embedded, substrate-binding protein), A/A= component (an energy-coupling module that comprises two ATP-binding proteins), and T component (a transmembrane protein) (14) (15) (16) . Recently, Hebbeln et al. (11) reported biochemical evidence that Rhodobacter capsulatus ECF transporter (BioMNY) and the single S component, the bioY gene product, can both actively function in biotin uptake.
Most of our current knowledge on regulation of bacterial biotin metabolism comes from studies with E. coli (1, 17) . Biotin protein ligase (BPL) is referred to as a universal enzyme widespread throughout all forms of life which covalently attaches biotin to its cognate acceptor proteins, such as the AccB subunit (also called the biotin carboxyl carrier protein [BCCP] ) of acetyl-CoA carboxylase (ACC), which catalyzes the first committed step of fatty acid biosynthesis (17) . The E. coli birA gene product is a model BPL that has undergone extensive investigations, ranging from genetics (18) (19) (20) and biochemistry (21) (22) (23) (24) (25) to structural biology/biophysics (21, 26, 27) . Unlike the group I BPL (also called monofunctional BirA) that lacks the N-terminal DNA-binding domain (1, 28) , the E. coli BirA is an unusual bifunctional BPL in that it also acts as a repressor for the biotin operon (1, 17, 29) . The fact that the E. coli BirA enzyme possesses these two divergent functions allows it to physiologically sense the intracellular levels of both biotin and unbiotinylated biotin-accepting protein BCCP (1, 18, 30) . The ligand of BirA repressor is biotinoyl-5=-AMP (also called biotinyl-adenylate), which is the intermediate of BirA-catalyzed ligation (31) . Upon excess biotin being present, biotinoyl-5=-AMP at high levels promotes accumulation of a ligand-bound form of BirA, the functional repressor complex at the bio operator, by triggering BirA dimerization, which consequently leads to the repression of the bio operon (1). Similarly, a high level of ligandbound BirA complex can accumulate when AccC is overproduced, because that tightly ties up the apo form of AccB in a complex with the poor biotinylation substrate (1, 29) . In contrast, the transcription of the bio operon can be derepressed once the concentration of liganded BirA is significantly decreased (1, 17) . In fact, this kind of situation might be easily triggered by either an inhibition of biotinoyl-5=-AMP formation by intracellular biotin limitation or by an increased consumption of biotinyl-adenylate due to overproduction of unmodified acceptor protein AccB (1, 29) . Earlier analyses of comparative genomics characterized GntR-type transcription factor BioR and its recognition signals (referred to as BioR box) upstream of biotin-related genes in a group of alphaproteobacteria, like Agrobacterium tumefaciens, and it was proposed that BioR was a new regulator of bacterial biotin sensing but required further experimental demonstration (32) . Very recently, we reported that the plant pathogen A. tumefaciens has evolved a new mechanism, a two-protein paradigm of BirA and BioR, to sense the demand of biotin, validating the above-described hypothesis of Rodionov and Gelfand (32) .
Brucellosis is an endemic disease with an estimated 500,000 cases globally each year, and pathogenic species of Brucella are the causative agents of such kinds of zoonotic infectious diseases (33) . According to the differences in their phenotypes and host habitats, the members of the Brucella genus have been classified into 10 known species plus one new strain, Brucella sp. NVSL 07-0026 (34-37) (http://en.wikipedia.org/wiki/Brucella). Among them, most Brucella genomes have been decoded (38) . In addition to the six earlier-recognized species, Brucella melitensis (sheep and goats), Brucella abortus (cattle), Brucella canis (dogs), Brucella neotomae (desert wood rats), Brucella ovis (sheep), and Brucella suis (pigs), there are five newly added species, namely, Brucella ceti from cetaceans, Brucella microti from voles, Brucella pinnipediae from pinnipeds, Brucella inopinata with an unknown host, and Brucella sp. NVSL 07-0026 from baboon (http://en.wikipedia.org /wiki/Brucella) (38) . Although bacterial biotin metabolism can be regarded as a promising/potential antibacterial drug target (39) , the regulatory mechanism in these pathogenic Brucella species remains poorly known. Surprisingly, our genomic sequencebased analyses of multiple Brucella species revealed that their bio operon encoding sequences (bioBFDAZ and bioY) and their promoter regulatory regions were almost 100% identical. This extreme conservation was also observed in the bioR orthologs. Unlike the scenario seen with A. tumefaciens that features only one BioR box located in the bioB locus (Fig. 1B) (32, 40) , four putative BioR palindromes in total were detected in each of the Brucella species (both bioR and bioY possess one site in the promoter region, whereas the bioBFDAZ operon contains two tandem BioR boxes), indicating a complicated regulatory network underlying their biotin-sensing machineries.
In this paper, we are the first to report a complex regulatory network of biotin metabolism found throughout all the species of Brucella. Using a LacZ reporter system that we developed on the basis of some engineered A. tumefaciens strains, we demonstrated that the Brucella melitensis BioR protein (BioR_bme) acts as a functional repressor for bio operon transcription (Fig. 1C) . Not only does BioR_bme negatively autoregulate itself, it also exerts repression on the expression of bioY that encodes a major player involved in biotin scavenging from the host and/or its inhabiting environment.
MATERIALS AND METHODS
Bacterial strains and growth conditions. E. coli strains are K-12 derivatives (Table 1 ) and grown at 37°C. A. tumefaciens strains used here were all engineered lacZ fusion reporter strains that we had recently developed (Table 1) (40) . The three kinds of media used for the maintenance of both E. coli and A. tumefaciens were Luria-Bertani (LB) medium (tryptone, 10 g/liter; yeast extract, 5 g/liter; NaCl, 10 g/liter; pH 7.5), rich broth (RB medium; 10 g of tryptone, 1 g of yeast extract, and 5 g of NaCl per liter), and a defined M9 minimal medium supplemented with 0.4% glucose or another carbon source, 0.1% vitamin-free Casamino Acids, and 0.001% thiamine. Mannitol-glutamate/Luria medium (MG/L medium; 5 g of mannitol, 1.16 g of monosodium glutamate, 12.5 g of LB broth, 0.1 g of MgSO 4 , and 1 mg of biotin per liter; pH 7.0) was utilized to prepare the competent cells of A. tumefaciens. Plasmids and molecular techniques. The B. melitensis bioR gene was synthesized in vitro here using an overlap PCR method. First, we amplified four pieces of overlapping DNA fragments using four sets of combined oligonucleotide primers (Table 2 ): (i) bioR BME -F1, bioR BME -F2, bioR BME -F3, and bioR BME -F4(r); (ii) bioR BME -F4, bioR BME -F5, bioR BME -F6, bioR BME -F7, bioR BME -F8, and bioR BME -F9(r); (iii) bioR BME -F9, bioR BME -F10, bioR BME -F11, bioR BME -F12, bioR BME -F13, and bioR BME -F14(r); (iv) bioR BME -F14, bioR BME -F15, bioR BME -F16, bioR BME -R2, and bioR BME -R1. The resulting four PCR products were mixed in equal ratios and used as the template for subsequent rounds of PCR in which the specific primers bioR BME -F and bioR BME -R1 were used ( Table 1 ). The resultant PCR product with an expected size of ϳ0.7 kb was purified and subjected to direct DNA sequencing. Finally, the B. melitensis bioR (bioRbme) gene was cloned into the pET28a expression vector via BamHI and XhoI cuts, creating the recombinant plasmid pET28-bioRbme ( Table 1 ). The isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible, tightly regulated expression vector pSRKGm (40, 41) was used for functional assays in A. tumefaciens. bioRbme was amplified with the bioRBME-CF and bioRBME-CR primers (Table 3 ) and inserted into pSRKGm via the NdeI and NheI sites, giving pSRK-bioRbme (Table 1) . There, promoter sequences of bioBbme (396 bp), bioYbme (372 bp), and bioRbme (377 bp) were synthesized by integrated DNA technology (IDT) and encoded by the following three plasmids: pIDT-PbioBbme, pIDT-PbioYbme, and pIDT-PbioRbme (Table 1) . Subsequently, the promoter regions were cut from the pIDT vector with SmaI and BamHI and cloned into pRG970, a low-copy-number lacZ reporter vector (42, 43) , via the same cuts, yielding pRG-PbioBbme, pRGPbioYbme, and pRG-PbioRbme, respectively ( Table 1 ). All the required recombinant plasmids were verified by either PCR detection, digestion of restriction enzymes, or direct DNA sequencing.
Expression, purification, and characterization of BioR proteins. The two versions of bacterial BioR proteins (referred to as BioR_bme and BioR_at for B. melitensis and A. tumefaciens, respectively) were produced in E. coli BL21(DE3) carrying the appropriate expression plasmids (pET28a-bioRbme and pET28a-bioRat; Table 1 ) and purified as described recently (40) with minor changes. The purified recombinant BioR_bme with a 6ϫHis tag at the N terminus was separated on a 12% SDS-PAGE gel and then confirmed using Western blotting assay with anti-6ϫHis primary antibody. The identity of BioR_bme was determined by liquid chromatography quadrupole time of flight (qTOF) mass spectrometry of tryptic peptides (44, 45) .
Electrophoretic mobility shift assays (EMSA). Gel shift assays were performed to test the binding of the BioR_bme to its cognate DNA sequences of B. melitensis as described by us earlier with minor changes (40, (45) (46) (47) . The digoxigenin (DIG)-labeled DNA probes (5 in total) were synthesized in vitro by annealing two complementary primers (Table 3) in TEN buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM NaCl; pH 8.0) and the terminal transferase-aided labeling with DIG-ddUTP (Roche). Native PAGE (8%) was utilized to detect the DNA-protein complex formed by an incubation of the DIG-labeled DNA probes (0.2 pmol) with/without BioR_bme (or BioR_at) in binding buffer (Roche) at room temperature for 20 min. Finally, signal capture was done by exposure to ECL film (Amersham) (44, 46) .
Biotin bioassay-based cross-feeding. To visualize the effect on biotin production exerted by bioRbme expression in A. tumefaciens, we designed a biotin bioassay-based cross-feeding experiment in which the biotin auxotrophic strain of E. coli, ER90 (⌬bioF bioC bioD), is cross-fed by A. tumefaciens species. The biotin-free M9 minimal medium plates were made as previously described (6, 40, 48) , containing 0.01% (wt/vol) redox indicator 2,3,5-tri- CG GGATCC ATG AAT CAG AAT GTC CCA GCC TCC CGG CCC GCT CCC CGG AGC GAA ACA ATT G bioR BME -F2 CTC CCC GGA GCG AAA CAA TTG CCG CCC GCA TCA GCC GCA TTC TCG CGG ATC GTA TCA TTG bioR BME -F3 (71-130) TTC TCG CGG ATC GTA TCA TTG CGG GCG AGA TCG AGC CCG GCA CCA AAC TGC GCC AGG ATC bioR BME -F4 (111-170) CAC CAA ACT GCG CCA GGA TCA TAT TGC CGA GGA ATT CCA GAC CAG CCA TGT GCC GGT GCG bioR BME -F5 (151-210) ACC AGC CAT GTG CCG GTG CGT GAA GCC TTC CGG CGG CTG GAG GCA CAG GGC CTC GCC GTT bioR BME -F6 (191-250) AGG CAC AGG GCC TCG CCG TTT CCG AAC CGC GGC GCG GCG TAC GCG TTG CCT CCT TCG ACA bioR BME -F7 (231-290) ACG CGT TGC CTC CTT CGA CAT TGG CGA AAT TCG CGA AGT GGC CGA AAT GCG CGC CGC GCT bioR BME -F8 (271-330) GCC GAA ATG CGC GCC GCG CTT GAG GTG CTT GCA CTG CGC CAT GCG GCC CCC CAC ATC ACC bioR BME -F9 (311-370) ATG CGG CCC CCC ACA TCA CCC GTG CCG TGC TGG ATG CCG CCG AAC AGG CCA CGC TGG AGG bioR BME -F10 (351-410) CGA ACA GGC CAC GCT GGA GGG CGA CAA GTC CCG CGA TGT GCG CAG TTG GGA AGA TGC GAA bioR BME -F11 (391-450) CGC AGT TGG GAA GAT GCG AAC CGG CGC TTC CAC CGT CTC ATT CTC ACC CCC TGC AAG ATG bioR BME -F12 (431-490) TTC TCA CCC CCT GCA AGA TGC CGC GCC TGC TCG CCG CCA TCG ACG ATC TTC ATG CGG CAA bioR BME -F13 (471-530)
CGA CGA TCT TCA TGC GGC AAG CGC CCG TTT TCT CTT CGC CAC CTG GCG CTC GGC ATG GGA bioR BME -F14 (511-570) ACC TGG CGC TCG GCA TGG GAA GCA CGC ACC GAC CAC GAC CAC CGC GCA ATC CTC GCC GCA bioR BME -F15 (551-610) ACC GCG CAA TCC TCG CCG CAC TGC GAC AAA ACG ATA TTG AAA GTG CGG CCA CCA TTC TCG bioR BME -F16 (591-650) AAG TGC GGC CAC CAT TCT CGC CCG CCA TGT GCA ATG GAT CGG CCA TCG CCC GGT CAA GAC bioR BME -R2 (631-690) CCC CAC AAT GGC GAA GGA ATC GCG CAC CTT TCC CGA AGC CGT CTT GAC CGG GCG ATG GCC bioR BME -R1 (671-693) CCG CTCGAG CTA CCC CAC AAT GGC GAA GGA AT bioR BME -F4(r) CGC ACC GGC ACA TGG CTG GTC TGG AAT TCC TCG GCA ATA TGA TCC TGG CGC AGT TTG GTG bioR BME -F9(r)
CCT CCA GCG TGG CCT GTT CGG CGG CAT CCA GCA CGG CAC GGG TGA TGT GGG GGG CCG CAT bioR BME -F14(r) TGC GGC GAG GAT TGC GCG GTG GTC GTG GTC GGT GCG TGC TTC CCA TGC CGA GCG CCA GGT a The numbers in parentheses denote the position of overlapping PCR primers relative to the coding sequence of bioRbme. b The underlined sequences are the introduced restriction sites. BioR bioB_at site-F 5=-CTC TCT TGA GGA GGC AAA AAT TAT CTA TAA TTT GCC ATT TAA CGA CCT GC-3= BioR bioB_at site-R 5=-GCA GGT CGT TAA ATG GCA AAT TAT AGA TAA TTT TTG CCT CCT CAA GAG AG-3= BioR bioR_BME site-F 5=-GAC CGC CGG GGC AAA GAA CAT TAT CTA TAA AAC CAT GAA TCA GAA TGT CC-3= BioR bioR_BME site-R 5=-GGA CAT TCT GAT TCA TGG TTT TAT AGA TAA TGT TCT TTG CCC CGG CGG TC-3= BioR bioY_BME site-F 5=-GAA TAG ATC GAG TCT CGA TTT TAT CTA TAA TTT GAG GAA ACC ATG GCG AC-3= BioR bioY_BME site-R 5=-GTC GCC ATG GTT TCC TCA AAT TAT AGA TAA AAT CGA GAC TCG ATC TAT TC-3= BioR bioB_BME site1-F 5=-CAC AAC TTC CCC CAT CAA AAT TAT CTA TTA TAT TAT CAT TTG TGG ATT CA-3= BioR bioB_BME site1-R 5=-TGA ATC CAC AAA TGA TAA TAT AAT AGA TAA TTT TGA TGG GGG AAG TTG TG-3= BioR bioB_BME site2-F 5=-TTT GCA GAT TGA TTC TGT TTT TAT CTA CAA TTT GGA GGA AGA ATG CCC TG-3= BioR bioB_BME site2-R 5=-CAG GGC ATT CTT CCT CCA AAT TGT AGA TAA AAA CAG AAT CAA TCT GCA AA-3= bioRBME-F (BamHI) 5=-CG GGATCC ATG AAT CAG AAT GTC CCA GCC-3= bioRBME-R1 (XhoI) 5=-CCG CTCGAG CTA CCC CAC AAT GGC GAA GGA AT-3= bioRBME-CF (NdeI) 5=-GGAATTC CATATG ATG AAT CAG AAT GTC CCA GCC-3= bioRBME-CR (NheI) 5=-CTA GCTAGC CTA CCC CAC AAT GGC GAA G-3= PbioBBME-check 5=-CTG GAG CAG TTT CGC TTA AC-3= PbioYBME-check 5=-ACT GCG ACA AAA CGA TAT TG-3= PbioRBME-check
5=-GTG AAA CTC GAC ACC TAC CTG-3= bioF-R (294-314) 5=-GTG GAA AGT GCT GCC AGA TTG-3= bioD-F (120-140) 5=-GAA GAA ACC GAC AGC GAG ATC-3= bioD-R (396-416) 5=-TGA TTG ATG GTG CCA AGG GCT-3= bioA-F (205-225) 5=-GAT CTG GAC CAG ATC ATC TTC-3= bioA-R (536-556) 5=-CTT CAA GAC GGT CGA GCA TAG-3=
a The underlined sequences are the introduced restriction sites. The bold letters are predicted core palindromes for BioR binding. .01 using a GntR regulator with known structure (PDB identifier 3C7J) of P. syringae pv. tomato strain DC3000 (accession no. AAO58874) as the structural template. N, N terminus; C, C terminus.
were cultivated in 5 ml biotin-free M9 minimal medium overnight. Subsequently, these overnight-grown cultures were collected by centrifugation (3,000 rpm, 10 min), washed three times using the M9 liquid medium, and transferred into 100 ml of biotin-free M9 medium for 6 more hours of growth at 30°C to exhaust trace amount of intracellular biotin in the biotin auxotroph strain FYJ283. Following three rounds of washing with the same medium, all the bacteria were suspended in M9 medium, and their optical densities at 600 nM were adjusted to 1.5. A total of 20 l of A. tumefaciens culture (OD 600 ϭ 1.0) was spotted on the paper disc and maintained at 30°C overnight. A red deposit of formazan suggested that the ER90 indicator strain is fed by the A. tumefaciens strains, and the red area of the growth circle (in square centimeters) represents the level of biotin produced by the different feeder strains. Genetic manipulations. Three plasmid-borne lacZ transcriptional fusions (pRG-PbioBbme, pRG-PbioYbme, and pRG-PbioRbme; in Table 1) were separately electroporated into the double-mutant strain of A. tumefaciens FYJ284 (⌬bioR::Km ⌬bioBFDA), yielding reporter strains FYJ319 (⌬bioR::Km pRG-PbioBbme), FYJ321 (⌬bioR::Km pRG-PbioYbme), and FYJ344 (⌬bioR::Km pRG-PbioRbme), respectively ( Table 1 ). In addition to the well-established reporter strain FYJ291 that carries the plasmidborne PbioBAT-lacZ transcriptional fusion (40) ( Table 1) , we introduced the low-copy-number expression plasmid (pSRK-bioRbme) into the above-listed three reporter strains for function analyses of Brucella bioR.
As we reported earlier (49) with little modifications, we deleted bioR (BMEI0320) from B. melitensis 16M using the strategy of homologous recombination. Both multiplex-PCR assays and direct DNA sequencing of PCR products were employed to confirm the acquired ⌬bioR mutant of B. melitensis (Table 1) .
RNA isolation and real-time quantitative RT-PCR. Bacterial total RNAs were isolated from the log-phase cells of B. melitensis 16M and its bioR isogenic mutant grown in TSB (OD 600 is around 1.0), using the RNeasy bacterial RNA isolation kit (Qiagen). The validated RNA samples in which contaminated DNA is not detected by general PCR with primers 16S-F and 16S-R (Table 3) were subjected to SYBR green single-step realtime reverse transcription (RT)-PCR experiments. A 16S rRNA gene acted as an internal reference gene, and five other genes of interest were bioB, bioF, bioD, bioA, and bioY ( Table 3 ). The relative expression levels were determined using the 2 Ϫ⌬⌬CT method reported by Livak and Schmittgen (50) .
␤-Galactosidase assays. Two different methods were adopted here to assay the ␤-galactosidase (␤-Gal) activity. First, the engineered A. tumefaciens reporter strains containing appropriate plasmids (Tables 1 and 3) were inoculated onto MacConkey agar plates with 0.4% lactose as the sole carbon source (Thermo Scientific) to initially visualize the differences in their LacZ activity. Second, we subjected the bacterial lysates sampled from the log phase of culture to a treatment with sodium dodecyl sulfatechloroform (51) to quantify their ␤-galactosidase activities in a manner similar to before (48) .
Bioinformatic analyses. The multiple alignments of either BioR protein or BioR-binding sites were conducted using the ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2/index.html), and final output was processed by the ESPript 2.2 server (http://espript.ibcp.fr/ESPript/cgi-bin /ESPript.cgi). The transcription start site was predicted using the method of Neutral Network Promoter Prediction (http://www.fruitfly.org/seq _tools/promoter.html).
RESULTS
Characterization of B. melitensis BioR. B. melitensis, a member of the alphaproteobacteria, contains two circular chromosomes: chromosome I (GenBank accession no. AE008917.1) is 2,117,144 bp long, while chromosome II (GenBank accession no. AE008918.1) is 1,177,787 bp in length (52) . A gene orthologous to bioR (BMEI0320) is located on chromosome I and encodes a 230-amino-acid polypeptide that is four residues longer than that of A. tumefaciens BioR (Fig. 2A) . Sequence alignment of these two BioR proteins (BioR_bme and BioR_at) showed that they share 76.5% identity and 65.5% similarity (Fig. 2A) . As predicted by Rodionov and Gelfand (32), these two proteins have a conserved N-terminal DNA-binding motif with a helix-turn-helix structure ( Fig. 2A and  F) . To test its putative function, we overexpressed the recombinant BioR_bme protein in E. coli and purified it to homogeneity (Fig. 2B) . Although the prevalent form (ϳ90%) of the purified BioR_bme protein when loaded on SDS-PAGE occurs at the position of ϳ26 kDa (which is consistent with the estimated molecular mass of its monomer), a small amount of protein (ϳ10%) is consistently present at the position of ϳ52 kDa, implying that BioR_bme can form a dimer in solution. To rule out the possibility for the impurities in the BioR_bme sample, we carried out Western blotting analyses with anti-6ϫHis tag primary antibody to address this issue. As expected, both forms of protein were recombinant forms of the protein with 6ϫHis tag (Fig. 2C) . Using the other approach, the chemical cross-linking assay, we also proved that the dimer form of the BioR_bme protein is appreciably increased upon addition of chemical cross-linker EGS, which is similar to our observation with A. tumefaciens BioR (Fig. 2D) 
FIG 3 Evidence that Brucella bioR is functional in vivo. (A) Expression of the
Brucella bioR homolog represses the transcription of the bioBFDA operon in A. tumefaciens. To visualize bioB-lacZ expression, we used a MacConkey agar plate with 0.4% lactose as a sole carbon source. The bacteria were maintained at 30°C for around 36 h. Purple indicates strong ␤-Gal activity, whereas yellow denotes no/low ␤-Gal activity. (B) Use of the ␤-Gal activity assay to test regulation of bioBFDA operon expression by two BioR orthologs (one is from A. tumefaciens and the other is from Brucella). Mid-log-phase cultures in RB medium were sampled for assays of ␤-Gal activity. The data are expressed as averages Ϯ standard deviations (SD), and error bars indicate SD. More than five independent experiments were performed. The three strains are FYJ291 (⌬bioRat), FYJ293 (⌬bioRat ⌬bioRat), and FYJ308 (⌬bioRat ⌬bioRbme). All the strains used here carry the PbioBat-lacZ transcriptional fusion (Table 1) . IPTG (0.3 mM) was used to induce expression of plasmid-borne bioRat (and/or bioRbme). (40) . Finally, liquid chromatography mass spectrometry of tryptic peptides demonstrated that the two protein bands cut from the gel indeed come from the same B. melitensis BioR protein, with a corresponding coverage score of 81% for the monomer form of 26 kDa (not shown) and 80% for the form of ϳ52 kDa (Fig. 2E) . It can be concluded that BioR_bme can exhibit the solution structure of the dimer, which is consistent with the scenario seen with BioR_at (40) .
B. melitensis bioR homolog is functional in vivo.
We recently engineered an FYJ291 reporter strain that is a double mutant of A. tumefaciens (⌬bioR ⌬bioBFDA) carrying the low-copy-number plasmid-borne bioBat-lacZ transcriptional fusion (40) . This reporter strain can indicate whether the bioR ortholog is functional or not. Upon growth on a MacConkey agar plate with 0.4% lactose as the sole carbon source, the FYJ291 reporter strain yielded purple colonies, indicating that the bioBat-lacZ fusion has strong ␤-Gal activity upon removal of BioR_at (Fig. 3A) . The introduction of BioR_at into this reporter strain resulted in the formation In the top panel, the identical residues are white letters with a red background, similar residues are black letters with a yellow background, and varied residues are in black letters. In the bottom panel, the sequence logo is generated using WebLogo (http://weblogo.berkeley.edu /logo.cgi). Designations: pd, Paracoccus denitrificans; Rsph, Rhodobacter sphaeroides; bme, Brucella melitensis; bj, Bradyrhizobium japonicum; at, Agrobacterium tumefaciens; ml, Mesorhizobium loti; Ssp, Silicibacter sp. TM1040. (C) The promoters of bioR, the bioBFDA operon, and bioY in Brucella. The predicted BioR site is given in red and underlined letters, and the possible ribosome binding site (RBS) is shown in purple and underlined type. The anticipated Ϫ10 and Ϫ35 regions are underlined in yellow. Abbreviations: S denotes transcription initiation site, and M denotes translation start site.
of yellow colonies, implying that extremely low ␤-Gal activity of bioBat-lacZ is due to efficient repression by the expression of BioR_at (Fig. 3A) . In general agreement with an observation with BioR_at, functional complementation of the FYJ291 indicator strain with plasmid-borne bioRbme also yielded the phenotype of yellow colonies (Fig. 3A) . Assays for LacZ activities further revealed that expression of both bioRbme and bioRat leads to a 8-to 10-fold decrement of the bioBat transcription level relative to that of the FYJ291 reporter strain with derepression of BioR (Fig. 3B) . Therefore, bioRbme is believed to be a functional orthologous gene in vivo. It seems quite likely that the BioR palindrome of A. tumefaciens bioB can be bound by both BioR_at and BioR_bme. B. melitensis BioR binds cognate palindromes. In chromosome I of B. melitensis 16M (GenBank accession no. NC_003317), the biotin transporter locus bioY (BMEI0319) that encodes a 191-residue polypeptide neighbors the gene bioR (BMEI0320). Each of them has a predictive BioR-binding site (Fig. 4A and B) (32) . In contrast, in its closely related organism A. tumefaciens, these two genes do not have any detectable BioR-binding sites in front of their coding sequences (32, 40) . In chromosome II of B. melitensis 16M (GenBank accession no. NC_003318), the genes consisting of the biotin biosynthetic pathway (BMEII0775, BMEII0776, BMEII0777, BMEII0778, and BMEII0779) are organized into the bioBFDAZ operon (Fig. 4A) . Unlike the scenario that only one BioR palindrome (TTATCTATAA) is determined to be in the very beginning of the bioB coding sequence from the A. tumefaciens bioBFDAZ operon, there are two discontinuous BioR recognized sites localized upstream of the translation start site of the B. melitensis bioBFDAZ operon (Fig. 4A and C) .
Systematic bioinformatics analyses by The Neutral Network Program of Promoter Prediction (http://www.fruitfly.org/seq _tools/promoter.html) suggested that the predicted transcription start site of bioR is a T 40 bp upstream of the ATG translation initiation site and the putative BioR-binding site (TTATCTA TAA) centered at position 31 (Fig. 4C) ; the transcription of the bioY gene begins at a T 17 bp upstream of the ATG translation start site that is also nearly in the center of the predicted BioR palindrome (TTATCTATAA) (Fig. 4C) ; the bioBFDAZ operon can be (Table 1) . (E) MacConkey agar plate-based observation revealed that expression of Brucella bioR was repressed by its own protein product. (F) Comparative analyses of ␤-Gal activity of bioRbme-lacZ fusion in the ⌬bioRat mutant and the complemented strain. Two strains assayed here are FYJ344 (⌬bioRat) and FYJ346 (⌬bioRat bioRbme), respectively (Table 1) . IPTG (0.3 mM) was used to induce expression of plasmid-borne bioRbme. Mid-log-phase cultures in RB media were sampled for assays of ␤-Gal activity. The data are expressed as averages Ϯ standard deviations (SD), and error bars indicate SD. More than five independent experiments were performed. (G) Real-time qPCR-based visualization for effect of bioBFDA and bioY expression exerted by Brucella BioR. Log-phase cultures of B. melitensis 16M grown in TSB were subjected to total RNA isolation. In the real-time qPCR experiment, each gene was assayed in triplicate. A representative result is given here.
transcribed in the beginning of an A (37 bp upstream of the ATG translation start site) that happens to separate the two BioR sites (site 1, TTATCTATTA; site 2, TTATCTACAA) (Fig. 4C) . Of note, the four above-described candidate BioR-recognizable sites required further experimental validation, and the diversity in their positions also raised the possibility that a complex regulatory network for biotin metabolism might exist. Gel shift assays confirmed that BioR_bme can efficiently bind the A. tumefaciens bioB promoter (Fig. 5A and B) , which generally validates our above-described observation that BioR_bme represses the expression of A. tumefaciens bioB in vivo (Fig. 3) . The bioRbme gene's own BioR-binding site was also demonstrated to be functional by in vitro EMSA (Fig. 5C and D) . Considering the fact that this BioR-binding site is located downstream of the predicted transcription start site (Fig. 4C) , we hypothesized that BioR_bme might be an autorepressor. Of particular note, our EMSA results proved that the earlier prediction by Rodionov and Gelfand (32) is correct in the case of the B. melitensis bioBFDAZ operon (Fig. 4) , i.e., the two tandem putative BioR palindromes in the promoter region of this operon both exhibit abilities to interact with the BioR_bme protein ( Fig. 5E to H) . This is somewhat unexpected but not without precedent. A scenario similar to what we have encountered is that two functional FadR-binding sites are present in the promoters of fadL and fadD, of which the protein products constitute the long-chain fatty acid (LCFA) transporter system in E. coli (48) . We thereby speculated that the two sites determined in this operon are under negative regulation by BioR in B. melitensis, but this hypothesis required further in vivo evidence. Additionally, the promoter region of the bioYbme gene that encodes the S component of the ECF-type biotin transporter (11, 13, 14) was shown to bind the BioR_bme protein in the in vitro assay (Fig. 5I and J) . This might represent the first example of the BioR-regulated transport/scavenge of biotin in bacteria.
To probe possible physiological ligands/effectors for BioR_ bme binding, we systematically tested the precursor (pimeloyl-ACP), intermediates (KAPA [7-keto-8-aminopelargonic acid], DAPA [7,8-diaminopelargonic acid] , DTB), and final product (biotin) of the biotin synthesis pathway (Fig. 6A) by employing the EMSA approach. Consistent with our recent observation with A. tumefaciens BioR, these biotin-related metabolites seemed to not interfere with the DNA-binding activity of BioR_bme, even with the addition of excessive metabolites (such as 500 pmol KAPA, DAPA, DTB, and biotin) (Fig. 6B and C) . Also, we observed that an excess of cold bioRbme DNA probe can efficiently/ competitively impair interaction between the DIG-labeled bioRbme DNA probe and the BioR_bme protein (Fig. 6C) , validating that this kind of DNA-protein binding is a specific physical interaction.
Complex regulation of biotin metabolism by BioR in B. melitensis. We applied two different approaches to dissect the in vivo role of B. melitensis bioR in biotin metabolism. One is an assay for LacZ activity in reporter strains, and the other is a quantitative PCR (qPCR)-based comparison of the bioRbme isogenic mutant with its parental strain of B. melitensis 16M.
First, we constructed three versions of plasmid-borne transcriptional lacZ fusions (PbioBbme-lacZ, PbioYbme-lacZ, and PbioRbme-lacZ) and then introduced them into the engineered strains of A. tumefaciens (⌬bioR ⌬bioBFDA) that we recently developed, giving three reporter strains, FYJ319 (⌬bioRat bioBbmelacZ), FYJ321 (⌬bioRat bioYbme-lacZ), and FYJ344 (⌬bioRat bioRbme-lacZ), respectively (Table 1 and Fig. 7 ). When grown on MacConkey agar plates with 0.4% lactose as the sole carbon source, all three reporter strains exhibited a similar phenotype of purple colonies (Fig. 7A, C , and E), indicating that this A. tumefaciens-based reporter system works well for our purpose. Upon in trans complementation of the pSRKGm-borne bioRbme gene separately into the above-listed three reporter strains, all the colonies with yellow color were consistently observed to grow on the MacConkey indicator plates (Fig. 7A, C , and E). Such a dramatic change in colony color clearly illustrated the in vivo effect of repression by BioR_bme on these target genes. In particular, bioRbme seemed to be negatively autoregulated, which contrasts with its counterpart in A. tumefaciens (32, 40) . Subsequent analyses of ␤-Gal activities revealed that (i) overexpression of bioRbme gave an 8-to 12-fold decrease of the bioBFDAZ operon expression (Fig. 7B) , which is generally consistent with our recent observation with bioRat (40), (ii) the expression level of the bioYbme transporter gene was reduced 3-to 5-fold in the presence of bioRbme expression (Fig. 7D) , and (iii) the amplitude for autorepression of BioR_bme itself was around 4-to 6-fold (Fig. 7F) .
Second, we carried out qPCR assays for further addressing the accumulated transcript level of the representative target genes (bioB, bioF, bioD, bioA, and bioY) in the bioR-disrupted mutant of B. melitensis 16M. The expression level of the bio operon in the ⌬bioRbme mutant was increased 2-to 3-fold relative to that of wild-type strain 16M (Fig. 7G) . Also, removal of the bioR gene from B. melitensis increased the bioY transcription to nearly 5-fold (Fig. 7G) . In general agreement with the data from the LacZ assays of reporter strains (Fig. 7) , real-time PCR analyses validated that BioR_bme functions as a repressor in vivo. Together, we concluded that it is very different from the scenario in A. tumefaciens and that a complex regulation network of biotin metabolism by BioR exists in B. melitensis: i.e., not only does BioR act as an autorepressor that negatively modulates the bio operon of the biotin biosynthetic pathway, it also represses the bioY transporter system (Fig. 1) . Although the bioY gene had been proposed for years (2, 53) , its regulated expression was very recently determined in Corynebacteria, i.e., it can be repressed by TetR-like transcription factor BioQ (54) . Therefore, our observation of bioY of B. melitensis is generally consistent with the scenario in Corynebacteria.
Physiological relevance of BioR regulation to biotin production. To gain a glimpse of the physiological consequence of BioR_bme-mediated regulation, we established a cross-feeding system in which the feeder strains are genetically modified A. tumefaciens species that are supposed to have different abilities to produce various levels of biotin (such as FYJ341, whose bioRat is inactivated from the chromosome, but it carries plasmid-borne bioRbme), and the recipient strain is a biotin auxotrophic strain of (62) was systematically analyzed using RegPredict software (61) . All the proposed BioR-binding palindromes listed in Table 4 were analyzed through WebLogo (http: //weblogo.berkeley.edu/logo.cgi), giving the sequence logo.
E. coli, ER90 (⌬bioF bioC bioD) ( Table 1 ). The growth medium we used here is biotin-free M9 minimal medium plates supplemented with 0.1% (wt/vol) of the redox indicator 2,3,5-triphenyl tetrazolium chloride (TTC) (6, 40, 48) . Since it is known that wild-type strain NTL4 of A. tumefaciens can produce high levels of biotin, most of which is secreted out of cells (40) , the ER90 indicator strain can be cross-fed, featuring a circle of a red deposit of formazan (Fig. 8) . In contrast, the FYJ283 (⌬bioBFDA) strain acts as a negative control and cannot support ER90 growth, given that both are biotin auxotrophic strains (Fig. 8) . The FYJ212 ⌬bioRat mutant seemed to produce appreciably more biotin than wild-type strain NTL4 and in turn trigger better growth of the indicator strain ER90, exhibiting bigger colony size (Fig. 8) . As we expected, the ER90 strain grew poorly upon expression of plasmid-borne bioRbme in the FYJ212 feeder strain, indicating that BioR_bme efficiently exerts negative regulation on the biotin biosynthetic pathway (Fig. 8) . To the best of our knowledge, this is the first report of the physiological relevance of BioR-mediated repression in bacterial biotin production.
DISCUSSION
BioR, belonging to a class of GntR-type transcription factors, is exclusively restricted to most alphaproteobacteria (32) and seems to compensate for the loss of regulatory function of BirA, a monofunctional biotin protein ligase (40) . We favored a two-protein model of BirA and BioR that might represent an alternative mechanism for bacterial biotin sensing. Given the fact that bioR duplication exists (e.g., Paracoccus denitrificans) (Fig. 9B) and that the number of BioR boxes varies greatly in different species (Fig. 9A  and B) , we believe that BioR-mediated regulation is definitely complex and diverse. We also noted that the BioR signal (BioRbinding palindromes) seems to be very conserved in the alphaproteobacteria we examined (Fig. 9C and Table 4 ), indicating that it might represent a common regulatory mechanism present in these organisms. Given the fact that all four Brucella BioR signals (including the bioRbme probe in Fig. 10A and B, the bioYbme probe in Fig. 10C and D, and the bioBbme probes 1 and 2 in Fig.  10E to H) can efficiently bind to an A. tumefaciens homolog of BioR, we are more confident in believing that this type of diversified regulatory mechanism is mediated by a relatively conserved DNA-protein interaction (Fig. 10) .
Here, we prove that Brucella BioR is a functional member using our newly engineered A. tumefaciens strain-based reporter system, suggesting that this approach serves as a useful tool with potent implications for functional assays of other bioR homologs. An unanswered question about this mechanism lies in the physiological ligand of BioR, which remains enigmatic. We had no success in ligand identification through examining a series of metabolite intermediates of biotin biosynthesis (Fig. 6 ) even after 3 years of a The BioR regulon was analyzed using RegPredict software (61) in 2 subdivisions of alphaproteobacteria (Rhizobiales and Rhodobacterales), which also can be accessed in much detail by using the RegPrecise database (62) . The position here is relative to the translation start site, and the score is measured using the recognition profile (position weight matrix). (40) . We anticipated that dissecting crystal structures of BioR protein alone and its complex with the DNA target might be helpful in obtaining clues regarding this question in the future. However, the unusual performance of this weird BioR protein in vitro (not only does it easily precipitate in a Superdex 200 column during the process of gel filtration but it also quickly deposits on the Millipore centrifugal filter units upon being concentrated) probably hampers the structure-based approach to this question (not shown). Recently, TetR-type transcription factor BioQ was reported to regulate biotin metabolism in Corynebacterium glutamicum (54) , which generally supports our hypothesis, i.e., diversified mechanisms have been evolving/developing for different bacteria to sense fluctuant biotin demands upon occupying various natural reservoirs or host environments. Brucella, the genus of Gram-negative facultative intracellular bacteria, consists of a group of heterogeneous populations with 10 classified species. Although the fact that the sequenced genomes of most Brucella species (9 out of 10 in total) vary in size, encoding 3,200 to 3,500 open reading frames (ORFs), the BioR regulator and its regulated bio operon and the BioR-binding sites are extremely similar (not shown), indicating that it is a conserved regulatory mechanism that is widespread in Brucella. Although the annotated locus of bioC (BMEI0182) that presumably encodes a putative O-methyltransferase is present in chromosome I of Brucella, no BioR-binding palindrome is detected (32) , suggesting that the earlier step of biotin synthesis is not the rate-limited step controlled by the BioR repressor. Intriguingly, two copies of bioY transporter genes (BMEI1431 and BMEI0319) with 52.7% similarity and 33.3% identity appeared on the same chromosome I; however, only the latter BMEI0319, adjacent to the locus bioR (BMEI0320), evolved to possess a BioR-recognizable site ahead of its coding sequence ( Fig. 4A and C) . We tend to believe that its physiological advantage for this biotin scavenge machinery (consisting of one regulated BioY transporter and one more unregulated one) is that of ensuring that the regulation of biotin uptake is not tightly controlled, in case it is encountering/inhabiting a host milieu with limited biotin availability. Retrospectively, such kind of regulated expression of biotin transporter bioY is somewhat similar to a scenario observed with long-chain fatty acid transporter fadL and fadD expression (48) . The fact that two BioR boxes are present in front of the bioBFDAZ gene cluster encoding protein products responsible for the formation of double rings in biotin molecule allows bacteria to finely/effectively modulate late steps of biotin synthesis, which is generally consistent with the scenario in E. coli, the paradigm organism (17, 55) . Differing from the simplified regulatory network of BioR in A. tumefaciens (40) , a functional dissection of Brucella BioR revealed quite a bit of the complex regulatory architecture of biotin metabolism (biotin transport system and biotin biosynthetic pathway), which might be a selective/adaptive consequence of the long-term coevolution of Brucella species to their unique inhabiting environment.
